T1	HMM 20 50	efficacy and safety evaluation
T2	HMM 123 142	efficacy and safety
T3	HMM 525 632	median number of angina attacks per week and the median number of nitroglycerin (NTG) tablets consumed/week
T4	HMM 813 845	frequency of angina attacks/week
T5	HMM 878 892	angina attacks
T6	HMM 922 938	self-assessments
T7	HMM 982 996	angina control
T8	HMM 1024 1059	ability to perform usual activities
T9	HMM 1108 1122	adverse events
T10	HMM 1165 1178	adverse event
T11	HMM 1189 1195	edema.
T12	HMM 1244 1271	incidence of angina attacks
T13	HMM 1292 1313	need of nitroglycerin
